Cargando…

Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes

Aims/Introduction:  Type 2 diabetes is progressive in that therapy must be altered over time, which is partly as a result of the progressive loss of pancreatic β‐cell function. To elucidate the relationship between residual endogenous insulin secretion and the necessity of insulin therapy to achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Shogo, Fujimoto, Shimpei, Hamasaki, Akihiro, Fujiwara, Hideya, Fujita, Yoshihito, Ikeda, Kaori, Takahara, Shiho, Nagashima, Kazuaki, Hosokawa, Masaya, Seino, Yutaka, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014971/
https://www.ncbi.nlm.nih.gov/pubmed/24843502
http://dx.doi.org/10.1111/j.2040-1124.2010.00096.x
_version_ 1782315270035996672
author Funakoshi, Shogo
Fujimoto, Shimpei
Hamasaki, Akihiro
Fujiwara, Hideya
Fujita, Yoshihito
Ikeda, Kaori
Takahara, Shiho
Nagashima, Kazuaki
Hosokawa, Masaya
Seino, Yutaka
Inagaki, Nobuya
author_facet Funakoshi, Shogo
Fujimoto, Shimpei
Hamasaki, Akihiro
Fujiwara, Hideya
Fujita, Yoshihito
Ikeda, Kaori
Takahara, Shiho
Nagashima, Kazuaki
Hosokawa, Masaya
Seino, Yutaka
Inagaki, Nobuya
author_sort Funakoshi, Shogo
collection PubMed
description Aims/Introduction:  Type 2 diabetes is progressive in that therapy must be altered over time, which is partly as a result of the progressive loss of pancreatic β‐cell function. To elucidate the relationship between residual endogenous insulin secretion and the necessity of insulin therapy to achieve good glycemic control, indices using serum C‐peptide immunoreactivity (CPR) were analyzed in patients with type 2 diabetes. Materials and Methods:  The data of 201 Japanese patients with type 2 diabetes who achieved the target of glycemic control during admission were analyzed retrospectively. Indices using CPR including fasting CPR (FCPR), CPR 6 min after intravenous injection of glucagon (CPR‐6 min), increment of CPR (ΔCPR), secretory unit of islet in transplantation index (SUIT) and C‐peptide index (CPI) were compared between the group requiring insulin (insulin group) and the group not requiring insulin (non‐insulin group). A receiver–operator characteristic (ROC) curve was made, and optimal cut‐off point and likelihood ratio were determined for each index. Results:  All indices of CPR were lower in the insulin group compared with those in the non‐insulin group. Likelihood ratios at the optimal point of FCPR, CPR‐6 min, ΔCPR, SUIT, and CPI were 2.0, 2.1, 1.6, 2.3 and 2.8, respectively. Optimal cut‐off point of CPI was 1.1 ng/mg. Sensitivity and specificity at optimal point of CPI were 61 and 78%, respectively. Conclusions:  The advantage of CPI of the indices of CPR to select insulin therapy to achieve good glycemic control was shown, but limitations of the predictive abilities of the indices using CPR should be taken into account. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2010.00096.x, 2011)
format Online
Article
Text
id pubmed-4014971
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-40149712014-05-19 Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes Funakoshi, Shogo Fujimoto, Shimpei Hamasaki, Akihiro Fujiwara, Hideya Fujita, Yoshihito Ikeda, Kaori Takahara, Shiho Nagashima, Kazuaki Hosokawa, Masaya Seino, Yutaka Inagaki, Nobuya J Diabetes Investig Articles Aims/Introduction:  Type 2 diabetes is progressive in that therapy must be altered over time, which is partly as a result of the progressive loss of pancreatic β‐cell function. To elucidate the relationship between residual endogenous insulin secretion and the necessity of insulin therapy to achieve good glycemic control, indices using serum C‐peptide immunoreactivity (CPR) were analyzed in patients with type 2 diabetes. Materials and Methods:  The data of 201 Japanese patients with type 2 diabetes who achieved the target of glycemic control during admission were analyzed retrospectively. Indices using CPR including fasting CPR (FCPR), CPR 6 min after intravenous injection of glucagon (CPR‐6 min), increment of CPR (ΔCPR), secretory unit of islet in transplantation index (SUIT) and C‐peptide index (CPI) were compared between the group requiring insulin (insulin group) and the group not requiring insulin (non‐insulin group). A receiver–operator characteristic (ROC) curve was made, and optimal cut‐off point and likelihood ratio were determined for each index. Results:  All indices of CPR were lower in the insulin group compared with those in the non‐insulin group. Likelihood ratios at the optimal point of FCPR, CPR‐6 min, ΔCPR, SUIT, and CPI were 2.0, 2.1, 1.6, 2.3 and 2.8, respectively. Optimal cut‐off point of CPI was 1.1 ng/mg. Sensitivity and specificity at optimal point of CPI were 61 and 78%, respectively. Conclusions:  The advantage of CPI of the indices of CPR to select insulin therapy to achieve good glycemic control was shown, but limitations of the predictive abilities of the indices using CPR should be taken into account. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2010.00096.x, 2011) Blackwell Publishing Ltd 2011-08-02 2011-01-04 /pmc/articles/PMC4014971/ /pubmed/24843502 http://dx.doi.org/10.1111/j.2040-1124.2010.00096.x Text en © 2011 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd
spellingShingle Articles
Funakoshi, Shogo
Fujimoto, Shimpei
Hamasaki, Akihiro
Fujiwara, Hideya
Fujita, Yoshihito
Ikeda, Kaori
Takahara, Shiho
Nagashima, Kazuaki
Hosokawa, Masaya
Seino, Yutaka
Inagaki, Nobuya
Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title_full Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title_fullStr Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title_full_unstemmed Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title_short Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
title_sort utility of indices using c‐peptide levels for indication of insulin therapy to achieve good glycemic control in japanese patients with type 2 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014971/
https://www.ncbi.nlm.nih.gov/pubmed/24843502
http://dx.doi.org/10.1111/j.2040-1124.2010.00096.x
work_keys_str_mv AT funakoshishogo utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT fujimotoshimpei utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT hamasakiakihiro utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT fujiwarahideya utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT fujitayoshihito utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT ikedakaori utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT takaharashiho utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT nagashimakazuaki utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT hosokawamasaya utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT seinoyutaka utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes
AT inagakinobuya utilityofindicesusingcpeptidelevelsforindicationofinsulintherapytoachievegoodglycemiccontrolinjapanesepatientswithtype2diabetes